ArticleArthroplasty today2026
Distal Femoral Triangle Combined With Distal Adductor Canal Block Offers Superior Analgesia and Functional Recovery After Total Knee Arthroplasty Compared to Adductor Canal Block and iPACK: A Randomized Clinical Trial.
Article in Arthroplasty today, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The distal femoral triangle block may provide better coverage of the saphenous nerve and the nerve to vastus medialis compared to the adductor canal block (ACB). Furthermore, anesthetic injection into the distal ACB may spread into the popliteal fossa, potentially alleviating posterior knee pain. Therefore, we aimed to evaluate the efficacy of the combined distal femoral triangle block and distal ACB (dFdA) for pain management following total knee arthroplasty (TKA). Methods: Patients (N = 70) were randomized to dFdA or ACB+iPACK groups. Primary outcomes were the numerical rating scale (NRS) for post-TKA pain during rest and movement, and total morphine consumption (TMC). Secondary outcomes included the timed up and go test (TUG), two-minute walk test (2MWT), active knee flexion, and five-times sit-to-stand test. Results: The dFdA group demonstrated significantly lower NRS for anterior knee pain during 6-48 hours and posterior knee pain during 6-18 hours post-TKA, both at rest and during movement, compared with the ACB+iPACK group. The dFdA group exhibited significantly reduced TMC at 24 ([interquartile range 4-6] vs [interquartile range 6-15], Conclusions: The dFdA demonstrates superior analgesic efficacy and could be a good alternative approach to enhance recovery for current clinical pathways of TKA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.